Eric Eskey writes about startup growth, AI and software businesses, and building Arizona’s innovation ecosystem. Eskey’s posts draw practical lessons from founder and industry conversations, including how to test ideas with customers, find durable markets, and scale companies.
AI is not the advantage; the founder's signal is · Durability test: what has to be true in 18 months · Speed only works inside a wedge; attack tiers in order
Eric Eskey writes about startups, software and AI, and Arizona’s innovation ecosystem.
Their posts turn founder and industry conversations into practical questions about how companies find demand, fit real workflows, and grow under constraints.
In one post, they distill advice on Israel’s tech ecosystem into a framework about small home markets, global ambition, resilience, and building companies for the long term.
Other examples apply that practical lens to founder-led marketing, health innovation, and cybersecurity.
Follow their work for concise interpretations of business discussions that connect broad industry shifts to choices founders, operators, and buyers can make.
Eskey does more than recap events: they identify the decision a conversation leaves unresolved and give readers a way to examine it.
After a cybersecurity summit, they ask buyers to assess what a vendor is pivoting from and to, and whether the change is real or stalled.
In a post about founder-led marketing, they distinguish the founder’s role—bringing customer evidence and judgment—from AI’s role in producing variations, then outline a routine for testing responses.
Other posts explore practical fit: health products must work within clinical workflows, and startup growth depends on customer demand rather than more features or meetings.
Their subjects range beyond technology to small-business financing, leadership, and Arizona’s health and business ecosystem.
Eskey draws on live conversations with founders, operators, investors, and health-system leaders, pulling out tests, sequences, and questions readers can apply: whether a product will survive platform copying, whether speed is being spent inside a focused market wedge, whether a vendor's pivot is operational or just vocabulary, whether a health solution fits clinical workflow, and whether capital access starts with relationships.
Read more
A consistent thread: what real customers, workflows, and constraints show matters more than generic enthusiasm for AI or growth.
AI is not the advantage; the founder's signal is
Eskey argues that using AI for marketing has become table stakes; the differentiator is the quality of the signal the founder supplies—customer language, objections, edge cases, and judgment.
Read more
They treat marketing as a learning system, not a content calendar: every asset should change a decision or trigger an experiment, and anything that does neither is noise. They warn against using AI to scale generic output faster.
At a PHX FWD talk by Nate Hurst, Eskey records the line 'This is not a differentiator for any of us anymore' and turns it into a weekly loop: pick one narrow segment, capture one or two raw signals a day, turn them into three hypotheses, generate variations with AI, ship, review responses the next morning, and kill anything that has not produced learning within five days.
A recurring question in Eskey's writing: will an AI product or company survive once platforms copy it, buyers get skeptical, or the workflow refuses to absorb it?
Read more
They argue that undifferentiated AI wrappers die, while trusted workflows survive. The test is whether the builder can answer that question in a sentence; if not, they say, the builder is funding a eulogy.
Eskey describes walking through a graveyard of failed AI tools with 153 headstones, 54 added that year, and lists five causes of death: generic wrappers eaten by base models, winners absorbed by acquisition, infrastructure consolidated into larger platforms, physical-world AI hitting complexity, and tools touching money, health, or family needing trust more than model quality.
They pair that with a line from an operator conversation: 'A report can be debated.
A prototype interacting with a real customer changes the room.' A small-business automation case offers the practical version: automate routine invoicing and order tracking, but keep human oversight.
Speed only works inside a wedge; attack tiers in order
Eskey's go-to-market lesson: speed is a force only when a company focuses on a specific market tier.
Read more
Skipping tiers in the name of speed scatters effort.
They argue that investors should be chosen for the doors and partnerships they bring, not for the valuation they post, and that the last 10 percent of product quality is the real work in regulated markets.
A separate panel adds that speed plus distribution is the default defensibility, workflow lock-in beats AI features, and go-to-market is becoming an engineering discipline.
From a PHX FWD Founder Friday with Rafael Loureiro of Wealth.com, Eskey lays out a bowling-pins sequence: independent IRAs at about $5k annual contract value, then broker-dealers, then enterprise wirehouses, because logos from the first tier unlock the second. Loureiro's advice includes running the customer's build-versus-buy decision with them by surfacing the five-year cost inside their own time horizon, and the line that generative AI has made 0-to-90 easy while 90-to-100 is the work.
Eskey reads industry events as strategic signals and asks what they mean for the buyer.
Read more
After a cybersecurity summit, they argue that every major incumbent was mid-pivot, leaving buyers to navigate vendors with overlapping vocabulary and old architectures. The diligence questions: what is the vendor pivoting from, what is it pivoting to, and is the pivot competent or stalled?
Eskey tracks Cisco moving from hardware to fabric, Cyderes from managed security to a context model, Kodem from package scanning to kernel truth, Splunk from SIEM to substrate, and Dataminr from intelligence vendor to predictive risk.
They note one speaker's line that attribution-before-incident is dead.
The sharpest observation: no speaker named the buyer's problem—how to discriminate among overlapping vendor stories in the same vocabulary.
Eskey argues that a small home market pushes founders to think globally from day one, while resilience helps them outlast capital cycles.
Read more
They frame the shift from 'start-up nation' to 'scale-up nation' as a strategic posture: build lasting independent companies rather than flip them.
At a panel hosted by Two Lanterns Venture Capital with Israeli operators and investors, Eskey reports a 70 percent drop in capital raised by Israeli venture funds and repeats the panel's examples of Fiverr and CyberArk scaling rather than exiting. They cite CyberArk's early refusal of acquisition as evidence that long-term building is now common, and repeat education and military-technology units as a talent pipeline.
Across two Arizona health-innovation events, Eskey argues that promising health products fail when they do not fit clinical workflows, institutional commitment, and real care pathways.
Read more
Scientific credibility is not enough; solutions need translation into practice.
They describe development projects as translation platforms and health systems as testbeds.
They also repeat a panelist's warning that the founder grind is not felt in Arizona the way it is in San Francisco or New York.
At FemTech AZ's women's health blueprint, Eskey reports Phoenix moving $50M from a tourism tax fund into bioscience with women's health named a priority; Mayo Clinic and ASU Health Care Accelerator's ten-day co-development model drawing companies from six countries; and HonorHealth's scale as a testbed—about three million patients a year and 4,500 nurses. From an Arizona Tech Week conversation on Mayo Clinic Arizona, they add that workflow fit beats innovation theater and that a shock such as COVID can expose whether early traction is durable.
Eskey's small-business funding writing focuses less on chasing capital than on building trust with funders early, knowing the financials, and understanding each funder's requirements.
Read more
They argue that money is not the end of the story; businesses also need to manage and multiply it. They point readers to diverse funding paths rather than a single lender.
At an Arizona small-business funding summit, Eskey lists CDFIs, a Kiva hub, SBA lenders, construction bridge financing for subcontractors, relationship-based banking, asset-based lending against receivables and inventory, character-based loans, and chamber support for contracts, bonding, and procurement. They explain the SBA's Capital Access Program as a temporary line of credit with lower fees and easier approval for businesses operating at least a year, and note a non-dilutive grant cycle moving to $100K in 2026.
Eskey argues that employee buy-in is earned through daily leadership behavior, not announced.
Read more
People join for a job, a future, and a life before they attach to a mission statement. They favor listening, empowering people with real ownership, and correcting in private while praising in public.
At an Ike Commercial Real Estate lunch-and-learn with Dr.
Will Moreland, Eskey records the line 'You didn't hire a position.
You hired a human being.' They single out questions such as 'Where do you see yourself in five years?' and 'How am I doing as a leader?' and close with the line that saying 'I'm proud of you' means you see me.
Start here for their clearest framework on how market size, capital pressure, and resilience can shape startup growth.
Eric Eskey turns a panel about Israel’s tech ecosystem into lessons on operating under constraints: a small home market encourages founders to think globally early, while resilience and long-term company building matter when capital is tight.
They point to Fiverr and CyberArk as examples of companies that grew beyond the startup stage.
The post offers a view of how Eskey connects ecosystem conditions to company strategy; ask for independent analysis of either company before drawing conclusions.
For brands planning a campaign
For a report on regional ecosystems, use the post to frame questions about whether local companies can reach global customers and build for scale rather than a quick exit. Pair those questions with independent company and funding data before drawing conclusions.
See how Eskey turns a broad claim about AI into a repeatable process—and why they put customer conversations before content production.
Read more
Eskey argues that AI use alone is no longer a marketing advantage.
A founder’s customer conversations, objections, and judgment provide useful input; AI can then turn a sharp insight into multiple marketing assets.
They make the idea practical with a routine: capture one or two signals a day, form hypotheses, generate variations, and review responses.
The approach treats marketing as a learning loop rather than a calendar of posts.
For brands planning a campaign
A B2B firm assessing regional startup resilience could use this as a discussion prompt about how founders learn from customers and test demand. A campaign based on it should focus on the learning process, not promise that AI output itself drives growth.
See Eskey apply their interest in startup growth to a regulated, operationally complex sector—and what they mean by durable fit beyond a promising idea or early traction.
Read more
From a conversation about Mayo Clinic Arizona, Eskey draws a specific warning: health innovation can fail when a product does not fit clinical workflows, even if the idea is promising.
They identify clinical translation, institutional commitment, and workflow reality as tests a solution must pass.
The example adds a useful counterweight to growth stories: in complex markets, scaling depends on fitting how people and organizations actually work.
For brands planning a campaign
For a regional innovation report, this post can support a framework for testing whether startups have access to real users, validation settings, and adoption pathways. Ask for independent evidence of health-system outcomes before relying on the post’s account of the discussion.
Read this for a concrete example of how Eskey extracts a decision test from a crowded industry conversation.
Read more
It shows their focus on what makes a company’s positioning credible in practice.
Eskey summarizes five cybersecurity speakers’ accounts of strategic shifts, then turns to the buyer’s problem: vendors may adopt new language while still operating on old architecture.
Their practical diligence question is what a vendor is pivoting from, what it is pivoting to, and whether the change is competent or stalled.
The post goes beyond listing event takeaways to identify a gap between vendor narratives and customers’ ability to judge them.
For brands planning a campaign
A report on startup resilience can adapt the question to evaluate whether a company’s strategic shift shows up in its product and operations, not just its pitch. Ask for current vendor status before relying on the conference discussion.
What has to be true for an AI product to exist in 18 months3
Capital access for small businesses and non-dilutive funding3
Arizona health innovation and the translation gap2
Founder-led marketing in an AI-saturated market1
Speed, distribution, and workflow lock-in as the durable moat1
Tiered go-to-market: bowling pins, not lottery tickets1
Resilience and global ambition from a small home market1
Cybersecurity vendor pivots and the buyer's silence1
Leadership as a craft, not a title1
Founder-led marketing in an AI-saturated market
Drawing on a PHX FWD talk by Nate Hurst, Eskey argues that using AI for marketing is no longer a differentiator; owning the signal is.
Read more
The founder is the source of truth for customer language, objections, and edge cases, while AI is the execution engine that turns one sharp insight into posts, emails, landing pages, and ad variants.
They reframe marketing as a learning system rather than a campaign calendar: every asset should change a decision or trigger an experiment, and anything that does neither is noise.
They close with a weekly operating loop — pick one narrow segment, capture one or two raw signals a day, turn them into three hypotheses, generate variations, ship, review responses the next morning, and kill anything that has not produced learning within five days.
Records the operative phrases from a live talk, then turns them into a numbered framework and a repeatable weekly loop.
For brands planning a campaign
For a firm evaluating founder-led go-to-market content, this piece shows Eskey translating a practitioner's talk into a testable operating model rather than an event summary.
Speed, distribution, and workflow lock-in as the durable moat
From a PHX FWD AI and enterprise-software panel, Eskey takes the claim that speed of execution is now the default defensibility, then qualifies it: in regulated or fragmented environments, the moat is integration and end-to-end workflow ownership, not AI features.
Read more
They note that proprietary system-of-record data buys a right-to-win only briefly, that go-to-market is becoming an engineering discipline (one panelist hired a go-to-market AI engineer to unify signals and reduce CRM drag), and that buyers asking language models for recommendations is opening a new GEO frontier. Other threads include security and AI infrastructure readiness as real work rather than a footnote, pricing simplifying away from credit models toward embedded AI, and the line that AI slop is human slop.
For brands planning a campaign
Relevant for vertical SaaS and AI product-strategy programming, where the useful content is the ranking of moats rather than the event recap.
Tiered go-to-market: bowling pins, not lottery tickets
A PHX FWD Founder Friday with Rafael Loureiro of Wealth.com, who raised a $65M Series A, yields a sequencing playbook.
Read more
Compress time inside the tier you are attacking instead of skipping tiers in the name of speed; attack wealth management as three bowling pins in order — independent IRAs at about $5k annual contract value, then broker-dealers, then enterprise wirehouses — because logos from the first tier unlock the second.
Pick investors for the doors they open and the partnership they bring, not the valuation they post.
When a customer threatens to build internally, run their build-versus-buy decision with them by surfacing the five-year cost inside their own time horizon.
In a regulated vertical, generative AI has collapsed the cost of demo quality while production quality is still the work, because 90 percent accuracy kills your customer.
For brands planning a campaign
For enterprise go-to-market and capital-strategy content, this is a concrete market-entry argument with named tiers, price points, and buyer psychology.
Resilience and global ambition from a small home market
A panel hosted by Two Lanterns Venture Capital with Israeli operators and investors yields Eskey's argument that a country the size of New Jersey keeps producing global technology companies because a small home market forces founders to think globally from day one.
Read more
They report a 70 percent drop in capital raised by Israeli venture funds and frame resilience as the differentiator that lets founders outlast the cycle.
The panel framed the shift from start-up nation to scale-up nation, with companies such as Fiverr and CyberArk scaling rather than exiting, and CyberArk's early refusal of acquisition as a sign that long-term building is now common.
They also repeat the education and military-technology pipeline as a talent source and the claim that the ecosystem rivals Silicon Valley in cybersecurity and AI.
The post reports one panel's consensus and repeats its figures. Before using the capital data or historical claims, ask for the underlying sources.
For brands planning a campaign
Useful regional-ecosystem material on how small markets manufacture global companies, with the resilience argument framed as a strategic posture rather than sentiment.
Two health-innovation events give Eskey a recurring frame: innovation fails on fit, not on ideas.
Read more
From FemTech AZ's women's health blueprint, they report Phoenix moving $50M from a tourism tax fund into bioscience with women's health named as a priority, the Mayo Clinic and ASU Health Care Accelerator's ten-day co-development model drawing companies from six countries, clinical demand built through menopause and sexual health fellowships, HonorHealth as a testbed with three million patients a year, and the State Forty Eight Foundation doubling grants to $100K with the next cycle in July.
From an Arizona Tech Week conversation on Mayo Clinic Arizona, they add that a development project such as Discovery Oasis is really a translation platform, workflow fit beats innovation theater, commitment and cultural alignment are part of the filter, and a founder's early traction can be exposed by a shock such as COVID.
They also repeat a panelist's line that the founder grind is not felt in Arizona the way it is in San Francisco or New York.
For brands planning a campaign
For health-system or regional innovation programs, Eskey can make the clinical-translation argument alongside specific local capital and testbed detail.
What has to be true for an AI product to exist in 18 months
A graveyard of failed AI tools — 153 headstones, 54 added this year — becomes a diligence exercise.
Read more
Eskey's five autopsy findings: generic wrappers got eaten when base models caught up; the actual winners were absorbed through acquisition; infrastructure tools consolidated into clouds, CRMs, and security platforms; anything mixing AI with the physical world, from hardware to clinics to bookkeeping to regulation, hit unforgiving complexity; and where a tool touched money, health, or family, trust mattered more than the model.
The operating question they take away is what must be true for a product to still exist in 18 months after platforms copy it, buyers get skeptical, or the workflow refuses to absorb it.
A separate post sharpens the standard: a report can be debated, but a prototype interacting with a real customer changes the room, which they call the difference between persuasion and signal.
A small-business automation case adds the practical side — automate invoicing and order tracking, keep strategic human oversight, and use AI to empower rather than replace.
For brands planning a campaign
For diligence or product-market-fit content, the through-line is a testable survival question plus direct customer contact, not deck rhetoric.
Capital access for small businesses and non-dilutive funding
An Arizona small-business funding summit gives Eskey a relationships-first thesis: build trust with funders early, know your financials and projections, understand how to manage money after receiving it, go broad across funding options, and tailor the approach to each funder's requirements.
Read more
They name the specific vehicles in the room — community development financial institutions, a Kiva hub, SBA lenders, construction bridge financing for subcontractors, relationship-based community banking, asset-based lending against receivables and inventory, character-based loans, and chamber support for contracts, bonding, and procurement.
A second post explains the SBA's Capital Access Program as a temporary line of credit with lower fees and easier approval that bridges the gap between work and pay for businesses operating at least a year.
The women's health post adds a non-dilutive grant cycle moving to $100K in 2026.
For brands planning a campaign
For SMB lenders, community development finance organizations, or ecosystem resource pages, Eskey can explain specific products and the relationship work that precedes an application.
Cybersecurity vendor pivots and the buyer's silence
At an Arizona Technology Council cybersecurity summit, Eskey reads five vendor talks as mid-pivot announcements: Cisco moving from hardware to fabric, Cyderes from managed security services to a context model, Kodem from package scanning to kernel truth, Splunk from SIEM to substrate, and Dataminr from intelligence vendor to predictive risk.
Read more
They summarize each speaker's framing — continuous vulnerability operations, organization-specific context that autonomous response can trust, runtime truth, the adversary's OODA loop inverted, attribution-before-incident as dead — then add their own thesis: the vendor evaluated 12 to 24 months ago is not the vendor pitching today, so diligence now asks what a company is pivoting from, what it is pivoting to, and whether the pivot is competent or stalled. Their sharpest observation: no speaker named the buyer's problem of discriminating among overlapping vendor stories in shared vocabulary.
Eskey summarizes speakers' positions as an attendee, not as an independent assessor. Ask for evidence that any named vendor's pivot is real and complete.
For brands planning a campaign
For a security-buyer audience, this is vendor-diligence framing written from the buyer's side of the table.
Will Moreland becomes a list of behaviors that earn employee buy-in.
Buy-in is earned, not announced; people joined for a job, a future, a mortgage, and a life before they ever attached to a mission statement; you did not hire a position, you hired a human being.
Eskey highlights listening questions such as where do you see yourself in five years and how am I doing as a leader.
They argue that empowerment means giving people something they can truly own, not delegating what you do not want to do, and repeat the rule to praise in public and correct in private.
Their closing line from the session: saying I am proud of you means you see me.
For brands planning a campaign
For leadership development or employer-brand work, Eskey can turn a live session into concrete behaviors a manager can adopt.
Eric Eskey's posts are field notes from founder, investor, and operator rooms in Arizona and Israel.
Read more
Start with the PHX FWD talk on founder-led marketing for an operating loop that turns customer signal into campaigns, or the Founder Friday recap of Rafael Loureiro for a tier-by-tier go-to-market sequence.
Readers weighing AI products should read the failed-AI-tools post, which turns 153 shutdowns into a survival test, and the panel notes on speed, distribution, and workflow lock-in.
For regional innovation, the Israeli venture panel and two Arizona health-innovation posts make the case for small markets, resilience, and clinical translation.
Cybersecurity buyers get a vendor-pivot diligence frame, small-business readers a map of lending and grant options, and people looking for management ideas the leadership lunch-and-learn.
Every post names the speakers, companies, and figures involved, so readers can trace the claims to the event itself.
Both write analytical posts about technology sectors and how companies from a small country reach larger markets.
Read more
Brog reads an Israeli defense procurement shift toward contested logistics and argues that firms with dual-use products are closer to U.S. contracts than defense pure-plays.
Eskey's Israeli venture panel makes a parallel argument: founders constrained by a small home market must think globally from day one.
Both treat an institutional credential — combat validation or a scale-up track record — as what opens the next market.
Brog covers defense and government procurement, offering market advice to companies selling to the Pentagon, with specific platform weights and ranges. Eskey stays on commercial and civic ground: local Arizona events, founder advice, health and small-business programs, with no defense-procurement or federal-contracting thread.
Both argue that AI in regulated sectors lives or dies on industry-specific safeguards and trust rather than model quality, and connect innovation to national and regional growth.
Read more
Margalit warns that AI-enabled attacks are moving from people-against-people to machines-against-machines and calls for vertical AI built around each industry's rules. Eskey makes the same trust-over-model point through the failed-tool graveyard, where tools touching money, health, or family died when trust did not hold.
Margalit writes as an investor advancing a named portfolio thesis, using companies as evidence and making an explicit policy ask of governments. Eskey reports what they heard in a room and gives the reader a test or a question, without naming a portfolio or advocating a policy position.
Both publish curated reads of the venture and startup landscape for founder and investor audiences, using capital figures as evidence rather than headlines.
Read more
Dineva counts 55 new funds and $16.8B in a single month, and ten U.S. rounds worth $2.86B in a week; Eskey cites a 70 percent drop in Israeli venture fundraising as the backdrop for the resilience argument.
Dineva publishes quantitative roundups of fund sizes, medians, stages, sectors, and geographies, with a database link, on a monthly and weekly cadence. Eskey's format is qualitative — lessons, sequences, and questions from live conversations — with numbers as context, not the product.
Use Eskey when a placement needs an Arizona startup, founder, and operator perspective—not proof of a specific buying committee or professional demographic.
Read more
Their public content aligns with founders, operators, investors, and ecosystem builders in Arizona tech, covering PHX FWD events, founder-led marketing, AI and vertical SaaS, cybersecurity, health innovation, SMB finance, and leadership.
The only published audience figure is 3,217 LinkedIn followers as of 8 October 2026.
The posts don’t identify followers’ location, employer, seniority, or buying role.
For a regional innovation ecosystems report, the content is relevant, but ask for recent audience survey results and platform demographics, especially geography, age, gender, employer, occupation, and seniority if those matter to the campaign.
Eric Eskey's posts do not describe a sponsorship, advertising, or paid-partnership format, and they provide no official partnership inquiry route.
Read more
They show them writing up founder and industry events — PHX FWD gatherings, Mayo Clinic and Arizona Tech Week panels, and an Arizona Technology Council cybersecurity summit — and thanking the organisations that hosted or sponsored those events, among them SVB, Deloitte, Morgan Stanley, and Ike Commercial Real Estate.
Those thanks recognise other parties' event sponsorship; they are not offers Eskey makes.
Before planning a brand partnership, ask Eskey directly about the format, terms, audience specification, lead time, and how to inquire; the posts provide no rate card or package structure.
A campaign fits Eric Eskey when the buyer wants a practitioner's synthesis of founder and ecosystem strategy, delivered as written analysis rather than reach.
Read more
A clear example: a venture firm, regional economic development body, or accelerator commissions an investor-facing report on how a small market produces companies that scale, with a working framework readers can apply.
That is the work their posts already do.
From a panel with Israeli founders and investors, they draw a strategic posture rather than sentiment: a small home market forces global thinking from day one, resilience lets founders outlast a capital cycle, and the framing shifts from start-up nation to scale-up nation, with Fiverr and CyberArk cited as companies that scaled instead of exiting.
From a founder talk, they build a tiering playbook with named tiers, price points, and a decision rule: attack wealth management as independent IRAs at roughly $5k annual contract value, then broker-dealers, then wirehouses, because logos from the first tier unlock the second.
They rank sources of defensibility in regulated software and reduce product survival to one answerable question: what must be true for this to still exist in 18 months after platforms copy it or the workflow refuses to absorb it?
In health, they apply the same test to clinical workflow fit and institutional alignment; in small-business finance, they name the actual capital vehicles in a market.
Three reasons this is a good match.
First, the method travels: they anchor a post in a real conversation, extract the operator's own language, then convert it into a numbered framework, a sequencing rule, or a short routine.
Second, they are a regional writer with genuine access to Arizona founder, investor, and health-innovation rooms—the setting a regional ecosystem report needs.
Third, the declared audience for this page—founders, operators, investors, and ecosystem builders—matches the content thematically, making a campaign aimed at that audience credible.
Set expectations: the posts show editorial synthesis and event-derived analysis, not commissioned research with verified data.
Agree on scope, outputs, and any original reporting obligations in writing.
Ask for a proposed delivery format and rate, since their public posts do not document a packaged offer, rate card, or delivery format.
When to choose a specialist
A campaign is a poor fit when it needs measured reach or an endorsement that conflicts with how Eric Eskey uses their material.
Read more
A clear example is a cybersecurity vendor buying a sponsored-post package with guaranteed delivery to enterprise security buyers, a stated impression or engagement target, and performance reporting.
Three problems are visible in the posts.
The audience number is thin: the only figure available is 3,217 LinkedIn followers observed 8 October 2026.
There is no information on who they are, where they work, their seniority, or their buying role, so no responsible plan can promise delivery to a specific buying committee.
No partnership format is documented either: their posts include no sponsorship policy, pricing, deliverable specification, lead time, or inquiry route.
Ask for those terms before planning a package.
The substance also conflicts with the campaign: in their cybersecurity write-up, they treat five vendor talks as pivots to interrogate rather than accept, and land on the buyer's problem—a vendor selling the new vocabulary while operating from the old architecture is the worst position to buy into.
A paid endorsement would undercut the judgment that makes that post worth reading.
Another poor fit is a campaign that requires verified market figures.
Their style is to report what speakers said and flag their own thesis alongside it.
The 70 percent drop in Israeli venture capital and the clinical and capital figures in the Arizona health and funding posts are event claims, not independently audited data.
A buyer needing sourced, defensible numbers must supply that research or accept the posts as attributed reporting only.
If a brand wants an Arizona founder-ecosystem read and is willing to define deliverables contractually, Eskey can be a reasonable fit; the failure here is in the campaign's shape, not the creator.
A worked campaign example
Worked campaign angle: a resilience and scaling framework for a venture firm or B2B software buyer, delivered as a short sequence of event-anchored analyses rather than a reach campaign.
The need: a firm preparing diligence guidance for portfolio companies wants a usable test of whether a startup's scaling plan is credible, illustrated with cases from real operators. Deliverable: a three-question framework, two worked examples, and a short routine readers can run.
The frame.
Question one: which tier are you attacking, and why that one first?
Use the tiered sequence from the Wealth.com founder talk—independent IRAs, then broker-dealers, then wirehouses—and the rule that speed only counts inside the tier you are attacking, because tier-skipping is where founders lose.
Question two: what must be true in 18 months for this to still exist after platforms copy it, buyers get skeptical, or the workflow refuses to absorb it?
Question three: where does workflow fit fail?
Apply the health-innovation version of the test: promising products still fail when they do not fit clinical or operational reality, and commitment and cultural alignment are part of the filter, not side notes.
Worked example one is the tiering case, with the detail that sells it: raising capital to compress time, choosing investors for the doors they open rather than the valuation they post, and, when a customer threatens to build internally, running their build-versus-buy decision with them by putting the five-year cost inside their own time horizon. Worked example two applies the survival question to a portfolio company, using the AI-tool autopsy findings: generic wrappers absorbed when base models caught up, winners acquired, infrastructure consolidated, anything touching the physical world hitting complexity, and trust mattering more than the model where money, health, or family is involved.
The format follows their established method: open with the strongest line from the conversation, give it as an attributable quote, convert it into a numbered takeaway list, then close with the repeatable routine—pick one narrow segment, capture one or two signals a day, form hypotheses, ship, review responses the next morning, and kill anything that has not produced learning within five days.
Why it suits Eskey: the angle uses operator language from real rooms, keeps every claim attributed to a named speaker, and delivers a decision tool instead of impressions.
Settle the exact outputs, length, number of pieces, and any original reporting required first.
Ask for audience measurement before setting a performance target.
Choose Tov Brog when the report's spine is defense and dual-use technology rather than a regional startup ecosystem.
Read more
Both posts here are written for Israeli companies selling into the United States.
One argues that a dedicated IDF artificial intelligence division gives defense firms a combat-validation credential that maps onto Pentagon programs such as JADC2 and Replicator, and lays out routes in through Foreign Military Sales, SBIR/STTR Phase III transitions, and OTA partnerships.
The other reads the Pentagon's 2026 critical technology list and concludes the money is moving toward contested logistics, making heavy-lift and autonomous resupply drones the stronger bet than loitering munitions.
For a venture firm whose portfolio sits in defense or dual-use hardware, that is a more directly usable market-entry analysis than a general resilience framework, and it names concrete procurement mechanisms instead of themes.
The narrower scope is the tradeoff.
Brog writes for defense and dual-use founders about access to United States government buying; Eric Eskey's posts here do not discuss how a small market builds general scaling companies, diligence questions for a software portfolio, or Arizona or regional ecosystems.
A firm commissioning a broad ecosystem report would be buying sector expertise it has to reframe itself.
Brog's method is also claim-led, with a strategic assertion followed by supporting detail, rather than the event-anchored synthesis with named speakers in Eskey's posts.
A reader who wants attributed operator language would get less of it.
Margalit when the report is about AI risk and regulated-industry adoption, and the buyer wants an investor's thesis rather than a framework.
One post argues that AI-enabled attacks give governments and critical industries only months to prepare, that Vertical AI built to one industry's rules is the answer for hospitals, banks, and utilities, and that agentic systems add risk because agents can be manipulated or impersonated; it names companies applying that approach in financial compliance, insurance, machine-identity management, and IT infrastructure.
The other is a reflection on Israel's next chapter that treats technology and innovation as an economic engine alongside rebuilding and social cohesion.
A firm writing about where AI goes next inside regulated sectors, or about Israel's innovation economy at national scale, gets a sharper and more opinionated read from this material.
The tradeoff is that this is argument plus portfolio illustration, not a repeatable evaluation method.
The posts state a position and point to examples, so a diligence team would still have to build its own questions and tests.
By contrast, Eric Eskey's posts hand over sequences and decision rules, such as which customer tier to attack first and which single question determines whether a product survives eighteen months.
Margalit's posts stay at the level of national and sector strategy, with no Arizona presence.
Both posts here date from September 2026, so a buyer would need more material to judge consistency over a longer stretch or breadth of topics.
Choose Ivelina Dineva when the report needs current capital-market numbers rather than operator judgment.
Read more
Her posts do a specific job.
One breaks down $16.8 billion in newly announced venture funds in a single month across fund size, geography, sector, and stage, flagging that 28 funds named AI and that seed was the most common stage.
The other lists the ten largest United States funding rounds of one week, about $2.86 billion total, with the investors named.
For a venture firm that wants to place a region or a sector against the flow of capital, or to give portfolio companies a recurring read on where money is going, that cadence and detail is more useful than a framework.
The posts also point readers to her own fund and accelerator databases, presenting the underlying data as a continuing resource.
The figures are reported as counts and totals with a link, leaving the reader to draw the implication; Eric Eskey's posts here offer a diligence question, a tiering rule, and a way to judge a single company.
There is no firsthand event reporting or named-operator language.
A firm seeking access to Arizona's founder, investor, and health-innovation communities should ask for that access explicitly rather than rely on market aggregation.
The two posts here date from early October 2026 and cover one month and one week, a different unit of analysis from a resilience and scaling framework.
This profile draws on 13 LinkedIn posts from Eric Eskey's account, covering events and programs referenced from 2024 through 2026, together with the account's profile information (3,217 followers, observed 8 October 2026).
Topics covered include founder-led marketing, AI product durability, go-to-market sequencing, cybersecurity vendor strategy, Arizona and Israeli startup ecosystems, health innovation, small-business funding and leadership.
Comparison notes for similar creators draw on posts by three other writers: Tov Brog (two posts dated November and December 2025), Erel N.
Margalit (two posts dated September 2026) and Ivelina Dineva (two posts dated October 2026).
Eskey's posts show their subject range, their habit of anchoring a post in a named speaker or event and converting it into a framework, and the specific claims they report.
Eskey's posts do not provide individual publication dates; no non-LinkedIn material, audience demographics beyond the follower count, engagement figures, or complete career history are available here; and no signature book, show or other landmark work is documented.
Capital and clinical figures that appear in the posts (for example, a reported 70 percent drop in capital raised by Israeli venture funds, or Arizona health-system patient numbers) are attributed to the speakers who gave them at those events and were not independently verified.
No sponsorship formats, rates or delivery terms are published in the posts here.
A name search that turns on a signature work such as a book, show or company role cannot be answered from Eskey's posts, and would need that primary information before it is added here.
